| Title | JCO Global Oncology |
| Abbreviation | JCO Glob. Oncol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q2); Oncology (Q2) |
| h-index | 39 |
| Overall Rank/Ranking | 3588 |
| SCImago Journal Rank (SJR) | 1.138 |
| Impact Score | 2.73 |
| Publisher | Lippincott Williams and Wilkins Ltd. |
| Country | United States |
| ISSN | 26878941 |
| Best Quartile | Q2 |
| Coverage History | 2020-2023 |
JCO Global Oncology is a journal covering the technologies/fields/categories related to Cancer Research (Q2); Oncology (Q2). It is published by Lippincott Williams and Wilkins Ltd.. The overall rank of JCO Global Oncology is 3588. According to SCImago Journal Rank (SJR), this journal is ranked 1.138. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 39. The best quartile for this journal is Q2.
The ISSN of JCO Global Oncology journal is 26878941. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. JCO Global Oncology is cited by a total of 1859 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of JCO Global Oncology is 2.73, which is computed in 2024 as per its definition. JCO Global Oncology IF is decreased by a factor of 0.93 and approximate percentage change is -25.41% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of JCO Global Oncology is 2.73. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.73 |
| 2022 | 3.66 |
| 2021 | 3.58 |
| 2020 | 1.87 |
| 2019 | 1.60 |
| 2018 | 1.94 |
| 2017 | 0.00 |
JCO Global Oncology has an h-index of 39. It means 39 articles of this journal have more than 39 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of JCO Global Oncology is 26878941. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of JCO Global Oncology is 3588. According to SCImago Journal Rank (SJR), this journal is ranked 1.138. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.138 |
| 2022 | 1.467 |
| 2021 | 1.302 |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 3588 |
| 2022 | 2222 |
| 2021 | 2676 |
| 2020 | 33709 |
| 2019 | 31348 |
| 2018 | 32843 |
| 2017 | 33593 |
JCO Global Oncology is published by Lippincott Williams and Wilkins Ltd.. It's publishing house is located in United States. Coverage history of this journal is as following: 2020-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of JCO Global Oncology is JCO Glob. Oncol.. This abbreviation ('JCO Glob. Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q2); Oncology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
JCO Global Oncology latest impact IF is 2.73. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.66 (2022) and 0.00 (2017), respectively, in the last 7 years. Moreover, its average IS is 2.2 in the previous 7 years.
The JCO Global Oncology has an SJR (SCImago Journal Rank) of 1.138, according to the latest data. It is computed in the year 2024. In the past 7 years, this journal has recorded a range of SJR, with the highest being 1.467 in 2022 and the lowest being in 2020. Furthermore, the average SJR of the JCO Global Oncology over the previous 7-year period stands at 2.2.
The latest h-index of the JCO Global Oncology is 39.
The JCO Global Oncology is published by the Lippincott Williams and Wilkins Ltd., with its country of publication being the United States.
The JCO Global Oncology is currently ranked 3588 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 7 years, this journal has experienced varying rankings, reaching its highest position of 2222 in 2022 and its lowest position of 33709 in 2020.
The standard ISO4 abbreviation for the JCO Global Oncology is JCO Glob. Oncol..
JCO Global Oncology is classified as a journal that the Lippincott Williams and Wilkins Ltd. publishes.
The JCO Global Oncology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The JCO Global Oncology is assigned the following International Standard Serial Numbers (ISSN): 26878941.
The best quartile for the JCO Global Oncology is Q2 (2023).
The JCO Global Oncology coverage history can be summarized as follows: 2020-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 9513 | Vilnius Gediminas Technical University | 48 | 3.30 |
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Indian Journal of Plastic Surgery | journal | 13847 | Thieme Medical Publishers, Inc. | 40 | 0.59 |
| Journal of Academic Ethics | journal | 10291 | Springer Netherlands | 30 | 2.62 |
| Qualitative Research | journal | 1588 | SAGE Publications Ltd | 93 | 4.87 |
| Journal of Business Finance and Accounting | journal | 2938 | Wiley-Blackwell Publishing Ltd | 91 | 3.64 |
| World Englishes | journal | 3418 | Wiley-Blackwell | 64 | 1.64 |
| Transnational Corporations | journal | 11181 | UNCTAD United Nations Conference on Trade and Development | 28 | 1.83 |
| Howard Journal of Communications | journal | 10151 | Taylor and Francis Ltd. | 39 | 1.66 |
| Studies in Continuing Education | journal | 7550 | Routledge | 40 | 3.04 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.73 |
| 2022 | 3.66 |
| 2021 | 3.58 |
| 2020 | 1.87 |
| 2019 | 1.60 |
| 2018 | 1.94 |
| 2017 | 0.00 |
